Home | About Us | Contact Us  
   
 
BACK TO INDEX
 
DAWN AC Anticoagulation Software E-Newsletter
   January 2008 
  IN THIS ISSUE
 
 
  • Brief Interruption of Warfarin - Low Risk of Thrombotic Events 
  • Joint Commission 2008 National Patient Safety Goals
  • Dawn AC 19th Benchmarking Run
  • Dawn AC User Survey
  • Comparative Study of Anticoagulation Care
  • Anticoagulation and Airbags - Dangerous Combination
  • Warfarin Drug stolen from Woman
  •  

     

     

     

    Welcome to the January edition of the DAWN AC Anticoagulation Software E-Newsletter for 2008.

     
     
     
     
     
     
    Brief Interruption of Warfarin Treatment has Low Risk of Thrombotic Events
    According to a prospective study published on the 15th of January this year, a short interruption of warfarin for a minor outpatient procedure has a low risk of a thrombotic event, with continued treatment resulting in a significant risk of bleeding.
     
    There are currently no specific guidelines as to whether to continue, stop or bridge patients on anticoagulants during a procedure, and surveys carried out have pointed to a large variation in processes for this across health care facilities.
     
    The US study used data on over 1000 patients and concluded that the risk of a thrombotic event after an interruption of warfarin therapy for 5 days was low.
     
    The researchers suggested peri-operative anticoagulation may not been needed in long-term patients. Bridging may result in an increased risk of bleeding, and so further trials may be required on this to establish to advantages and disadvantages.
     
    It was mentioned that although the study was quite big in size, the number of events were small, and so this study could not make any definitive conclusions regarding the therapy needs of any particular patient. It may however provide some help when healthcare professionals make decisions on whether to stop, continue or bridge a patient during a procedure.
     
    To view more of this article, follow the link below:
     
     
    Joint Commission in USA Releases 2008 National Patient Safety Goals
     
     
    The Joint Commission's Board of Commissioners in the USA approved the National Patient Safety goals for 2008 late last year, with a new goal specifically for anticoagulation this year expected to be implemented by accredited healthcare organisations by January 2009. This new goal is as follows:
    • "Reduce the likelihood of patient harm associated with the use of anticoagulation therapy. [Ambulatory, critical access hospital, home care, hospital, long term care, office-based surgery]"
    The Joint Commission will survey all accredited healthcare organisations for the implementation of all applicable goals as of January 1, 2008.

    To read more of this article, follow the link below:
     

    What does this mean for Dawn AC users? Please let us know by sending an email to sales@4s-dawn.com

    Dawn AC Nineteenth Benchmarking Run

     
    Eighty-two centres from around the world participated in the 19th Benchmarking run recently, analysing data for the period May 2007 to October 2007. Data from 216,000 patients with over 1,700,000 INRs across four target INR ranges were analysed. 
     
    Here is a summary of the results produced (across all target ranges and all time periods):
     
    Site

    % time in range

    % time above

    % time below

    % of INRs > 5

    % of INRs < 1.3

    Best

    75.69

    10.27

    14.05

    0.71

    1.00

    Worst

    56.61

    14.34

    29.05

    3.13

    6.39

    Average

    68.71

    13.88

    17.41

    1.92

    2.85

     
    Participating members should have received their comprehensive reports showing how they have performed over the last six months.

    If you are not a benchmarking participant and would like more information, then please email us at sales@4s-dawn.com.
     

    Dawn AC User Survey - Deadline 31st of January 2008

     
    We recently sent out a Dawn AC User survey to our customers and benchmarking participants, in order to find out about the type and scale, roles and responsibilities and procedural methods of typical healthcare organisations.
     
    The survey covers the following areas:
    Type and Scale of Services
    Analysis of Staffing
    Responsibilities
    Procedures and Performance
     
    Once the data has been collected this will be made available to all who participated in the survey via the internet.

    This information can help when seeking funding for any service improvements you have planned, and so if you have not completed our survey yet then please consider doing so before the 31st of January 2008 deadline.

    If you are a Dawn AC user who has not received a survey via email, and would like to participate, then please email us at sales@4s-dawn.com.
     

    Comparative Study of Anticoagulation Care Against Usual Care in Monitoring Non Valvular AF Patients

     
     
    A US study published recently has suggested that anticoagulation services have a positive impact on therapy outcomes, and points to the importance of providing these services to patients on anticoagulants.
     
    The study used data from 1107 patients, 351 registered with an anticoagulation clinic, and 756 'usual care' patients, and estimated the time in range and the time until a first major event (bleed or stroke) between March 2001 and March 2004.
     
    It was found that the patients registered with an anticoagulation clinic spent more time in therapeutic range, and were 59% less likely to have a bleed following the index date that usual care patients.

    The read more of this article, follow the link below:
     
     
    Oral Anticoagulation and Air Bags: Dangerous Combination in Accidents
     
    Researchers in Austria have produced a case report which suggests that patients on anticoagulants are at risk of injuries when an air bag is deployed during a low-speed car accident.
     
    Although air bags are known to significantly reduce the risk of serious injury in car accidents, the report highlights the case of a 65 year old woman who was admitted to hospital after receiving a blunt air bag related trauma to the head during a low speed car accident. The woman was examined and medics found no external injuries, with the patient experiencing no symptoms such as headaches and nausea. However, a CT scan revealed a discrete subarachnoid hemorrhage, and the woman died shortly after following a hematoma. The woman had been receiving anticoagulant therapy for the past two years for chronic atrial fibrillation.
     
    It was concluded that maintaining an adequate distance to an air bag may reduce the risk of head injury, and patients should be aware of the potential risk when in a car.

    To access more of this article, follow the link below:
     
    Warfarin Drug Stolen from Woman
     
    Police are in search of thieves who snatched the drug warfarin from a woman recently. The incident occurred in Penwortham, Lancashire, last week when two males approached the woman as she was walking along the road. The woman had just picked up her warfarin medication from the chemist before she was approached.
     
    The men snatched the woman's bag from her and stamped on her foot when she tried to resist. The pair then ran off with the bag.
     
    DS John Cass, of South Ribble CID, said: "The woman has been left very shaken and is obviously concerned at the missing medication because of the dangers that could arise. It is not clear what quantity of the drug was taken but it was a full prescription."
     
    Police are currently appealing for witnesses to come forward.
     
    To read more of this article, follow the link below:
     
     
     
     
    Phone: +44 (0) 15395 63091